How many insider trades does FilingIQ track for COAG?

FilingIQ tracks 39 Form 4 insider transactions for COAG (Hemab Therapeutics Holdings, Inc.), covering filings from Jan 29, 2026 onwards. 36 of those were filed in the last 90 days.

Are COAG insiders net buyers or net sellers?

Across the full Form 4 history for COAG, 16 transactions (41%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does COAG insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is COAG in?

Hemab Therapeutics Holdings, Inc. (COAG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.27B.

COAG insider trading

NasdaqGS Healthcare

Hemab Therapeutics Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

41% / 0%

Market cap

$1.27B

About Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.

Company website: www.hemab.com

COAG insider activity at a glance

FilingIQ has scored 39 insider transactions for COAG since Jan 29, 2026. The most recent filing in our index is dated Jun 16, 2026.

Across the full history, 16 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on COAG insider trades is 52.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live COAG trades on FilingIQ Raw filings on SEC EDGAR

Latest COAG Form 4 filings

RA CAPITAL MANAGEMENT, L.P.

P May 4, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,165

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for COAG?: FilingIQ tracks 39 Form 4 insider transactions for COAG (Hemab Therapeutics Holdings, Inc.), covering filings from Jan 29, 2026 onwards. 36 of those were filed in the last 90 days.
Are COAG insiders net buyers or net sellers?: Across the full Form 4 history for COAG, 16 transactions (41%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does COAG insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is COAG in?: Hemab Therapeutics Holdings, Inc. (COAG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.27B.

Methodology & sources

Every COAG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.